Mizuho Raises Cigna Price Target Citing Regulatory Stability in Managed Care

Key Facts

Amid improving prospects for the U.S. health insurance industry, Mizuho has raised its price target for Cigna (CI) from $330 to $340 while maintaining an Outperform rating. Analyst Ann Hynes expects a reduction in policy-related surprises within the managed care sector, allowing investors to shift their focus back to company fundamentals. This positive outlook is supported by a more stable regulatory environment and better-than-expected Medicare Advantage rates that have bolstered analyst confidence.

This upward revision comes as the healthcare sector finds its footing relative to peers; while recent earnings from UnitedHealth (UNH) highlighted some medical cost pressures, Cigna has maintained resilient margins through its diversified service offerings. Per market data, Cigna is currently trading at attractive valuation multiples compared to its historical sector average, reinforcing Mizuho's view that much of the regulatory risk is already priced into the equity.